Skip to main content
. 2022 Feb 12;9(15):2003699. doi: 10.1002/advs.202003699

Table 1.

Summary of representative ocular nanomedicine for ocular disease treatment

Nanoformulations Cargos Administrations Functions/Applications Reference
Liposomes CRISPR‐Cas9 ribonucleoprotein complex Subretinal injection Inducing efficient genome editing in vivo [ 94 ]
Nanostructured lipid carriers Dasatinib Topical administration Increasing the solubility of dasatinib, sustaining drug release, reducing ocular toxicity, and facilitating its penetration into cornea [ 23b ]
Solid lipid nanoparticles RS1 DNA plasmid Intravitreal injection Improvement of retinal structure by extending therapeutic period up to 2 weeks [ 22a ]
DSPE‐PEG2000‐cRGD nanomicelle Flurbiprofen Eye drops Specifically targeted combining to integrin receptors on cornea surface and facilitated rapid mucoadhesion [ 28 ]
Boronic acid‐rich dendrimer Superoxide dismutase Intravitreal injection Protecting retinal function and reducing cell apoptosis by high levels of cellular uptake without immunogenicity and cytotoxicity [ 33 ]
DNA/PLGA hybrid hydrogel Dexamethasone Topical administration Improving dexamethasone accumulation and mediating gradual dexamethasone release [ 4 ]
Chitosan‐based self‐assembly nanofilms Heparin Cornea in situ self‐assembly Rescuing corneal defective wound healing [ 45 ]
Mesenchymal stem cells‐derived exosomes Intravitreal injection/eye drops Significantly anatomical and functional restoration of retina, optic nerve, or cornea by modulating angiogenesis and inflammation, and improving immunomodulation and tissue regeneration [ 66 , 67 , 68 ]
Palladium‐coated gold nanorods Being pasted to lacrimal gland Sensing diverse visible light irradiations and spontaneously responded by heating up to secrete more tears to prevent dry eye [ 50 ]
Nanoceria Doxorubicin Intravitreal injection Sensitive to extracellular acidic pH conditions, targeted to tumor cells, instantaneously inducing ROS, and releasing doxorubicin intracellularly to enhance the chemotherapeutic activity in retinoblastoma cells [ 122a ]
Gold nanoparticles‐based nanobubbles Hyaluronic acid Intravitreal injection Mechanically ablating the vitreous opacities upon local pulsed‐laser illuminates to generate vapor nanobubbles [ 51 ]
Dichalcogenides quantum dots Eye drops Antibacterial agent with a fast response and no reliance on light [ 57 ]
Mesoporous silica nanoparticles Bevacizumab Intravitreal/subconjunctival injection Suppressing corneal and retinal neovascularization [ 62 ]
Spermidine‐derived carbon quantum dots Eye drops Strong antibacterial capabilities for treatment of bacterial keratitis [ 10c ]
Graphene‐coated contact lens Wearing on the ocular surface Monitoring changed water evaporation rate and protecting eyes from electromagnetic wave damage [ 59 , 60 ]
Thermosensitive triblock copolymer Acriflavine hydrochloride and sunitinib malate Topical administration Increasing the intraocular absorption of hydrophilic and hydrophobic drugs and extending the drug–ocular–epithelium contact time [ 140 ]
PEG‐b‐poly(propylene sulfide) nanomicelles Actin depolymerizer latrunculin A Intracameral injection Selectively modulating stiffness of Schlemm's canal cells for therapeutic reducing intraocular pressure [ 105 ]